Endoscopic, endonasal management of sinonasal haemangiopericytoma: 12-year experience

J Laryngol Otol. 2010 Nov;124(11):1178-82. doi: 10.1017/S0022215110000952. Epub 2010 May 4.

Abstract

Aim: To report our experience with endoscopic, endonasal management of sinonasal haemangiopericytoma.

Materials and methods: Retrospective review of the medical records of 10 patients undergoing endoscopic, endonasal surgery for sinonasal haemangiopericytoma of the nose and paranasal sinuses, between 1997 and 2008.

Results: Five men and five women were included. Their mean age at surgery was 59 years. All patients underwent endoscopic, endonasal resection of their tumour. Major post-operative complications were encountered in only one patient (stroke). Local recurrence was diagnosed in only one patient (10 per cent), who subsequently underwent a combined resection (endoscopic and external) with orbital exenteration.

Conclusions: Sinonasal haemangiopericytomas are rare tumours that are usually benign. The mainstay of treatment is wide surgical excision with free resection margins. Nowadays, the great majority of patients can be treated using a purely endoscopic, endonasal approach.

MeSH terms

  • Adult
  • Aged
  • Endoscopy / methods*
  • Female
  • Hemangiopericytoma / pathology
  • Hemangiopericytoma / surgery*
  • Humans
  • Length of Stay
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / surgery*
  • Neoplasm Staging
  • Nose Neoplasms / pathology
  • Nose Neoplasms / surgery*
  • Paranasal Sinus Neoplasms / pathology
  • Paranasal Sinus Neoplasms / surgery*
  • Reoperation
  • Retrospective Studies
  • Treatment Outcome